Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate

British Journal of Cancer

Volumn 74, Issue 8, 1996, Pages 1223-1226

  Bolger, B S ^a,b,e   Symonds, R P ^b   Stanton, P D ^a   MacLean, A B ^c   Burnett, R ^b   Kelly, P ^d   Cooke, T G ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Bromodeoxyuridine; Cervical carcinoma; Proliferation rate; Radiotherapy

Indexed keywords

BROXURIDINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR RECURRENCE; UTERINE CERVIX CARCINOMA;

EID: 0029807202     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.520     Document Type: Article

References (21)

1. BEGG AC. (1994). Prediction of repopulation rates and radio-sensitivity in human tumours. Int. J. Radiat. Biol., 65, 103 - 108.
2. BEGG, AC, MCNALLY NJ, SHRIEVE DC AND KARCHER H. (1985). A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry, 6, 620 - 626.
3. BEGG AC, MOONEN I, HOFLAND I, BESSING M AND BARTELINK H. (1988). Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intertumoural sampling variations. Oncology, 11, 337 - 347.
4. BEGG AC, HOELAND I, VANGLABEKKE M, BARTELINK H AND HOROIT JC. (1992). Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: EORTC cooperative trial 22851. Semin, Radiat, Oncol., 2, 22 - 25.
5. BOLGER BS, COOKE TG, SYMONDS RPS, MACLEAN AB AND STANTON PD. (1993). Measurement of cell kinetics in cervical tumours using bromodeoxyuridine. Br. J. Cancer, 68, 166 - 171.
6. COLE DJ, BROWN DC, CROSSLEY E, ALCOCK CJ AND GATTER KC. (1992). An assessment of the relationship of tumour proliferation to prognosis. Br. J. Cancer, 65, 783 - 785.
7. CREASMAN WT. (1995). New gynaecologic cancer staging, Gynaecol. Oncol., 58, 157 - 158.
8. DAVIDSON SE, SYMONDS RP, LAMONT D AND WATSON ER. (1989). Does adenocarcinoma of the uterine cervix have a worse prognosis than squamous carcinoma when treated by radiotherapy. Gynaecol. Oncol., 33, 23 - 26.
9. DAVIDSON SE, WEST CM, ROBERTS SA, HENDRY JH AND HUNTER RD. (1990). Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother. Oncol., 18, 349 - 356.
10. DIXON B, WARD AJ AND JOSLIN CA. (1977). Pre-treatment 3H-TdR labelling of cervical biopsies: histology, staging and tumour response to radiotherapy. Clin. Radiol., 28, 491 - 497.
11. LEVINE EL, DAVIDSON SE, ROBERTS SA, CHADWICK CA, POTTEN CS AND WEST CM. (1994). Apoptosis as a predictor of response to radiotherapy in cervical carcinoma (letter), Lancet, 344, 472.
12. NAUS GJ AND ZIMMERMAN RL. (1991). Prognostic value of flow cytophotometric DNA content analysis in single treatment stage IB IIA squamous cell carcinoma of the cervix. Gynecol. Oncol., 43, 149 - 153.
13. SAUNDERS MI, DISCHE S, GROSCH EJ, FERMONT DC, ASHFORD RF AND MAHER EJ. (1991). Experience with CHART [published erratum appears in Int. J. Radiat. Oncol. Biol. Phys., 1991, 21(6), 1683]. Int. J. Radiat. Oncol. Biol. Phys., 21, 871 - 878.
14. STEEL GG. (1977). Growth Kinetics of Tumours, Clarendon Press: Oxford.
15. STRANG P, EKLUND G, STENDAHL U AND FRANKENDAL B, (l987a). S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix. Anticancer Res., 7, 807 - 810.
16. STRANG P, LINDGREN A AND STENDAHL U. (1987b). Blood group antigens in relation to DNA content, S-phase rate and heterogeneity, and their prognostic values in cervical carcinoma. Anticancer Res., 7, 125 - 128.
17. TROTT KR AND KUMMERMEHR J. (1985). What is known about tumour proliferation rates to choose between accelerated fractionation and hyperfractionation? Radiother. Oncol., 3, 1 - 9.
18. pot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Int. J. Radiat. Oncol. Biol. Phys., 32, 1319 - 1329.
19. VAN NAGELL JR. Jr, RAYBURN W, DONALDSON ES, HANSON M, GAY EC, YONEDA J, MARAYUMA Y AND POWELL DF. (1979). Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer. 44, 2354 - 2361.
20. WILSON GD, MCNALLY NJ, DISCIIE S, SAUNDERS MI, DES ROCHERS C, LEWIS AA AND BENNETT MH. (1988). Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br. J. Cancer, 58, 423 - 431.
21. ZANETTA GM, KATZMANN JA, KEENEY GL, KINNEY WK, CHA SS AND PODRATZ KC. (1992). Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma. Gynecol. Oncol., 46, 13 - 19.